BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 4389248)

  • 1. Laboratory evaluation of erythromycin in a general hospital.
    Watson KC
    S Afr Med J; 1969 May; 43(20):577-9. PubMed ID: 4389248
    [No Abstract]   [Full Text] [Related]  

  • 2. [On the effect of hexetidine in vitro].
    Linzenmeier G
    Arzneimittelforschung; 1969 Feb; 19(2):164-7. PubMed ID: 4388760
    [No Abstract]   [Full Text] [Related]  

  • 3. [Present status of bacterial resistance to antibiotics and chemotherapeutic drugs and a tendency towards the development of resistance].
    Fritsche D; Schulz-Stübner A
    Dtsch Med Wochenschr; 1972 Dec; 97(51):1963-8. PubMed ID: 4404874
    [No Abstract]   [Full Text] [Related]  

  • 4. Susceptibility of common pathogenic bacteria to seven tetracycline antibiotics in vitro.
    Steigbigel NH; Reed CW; Finland M
    Am J Med Sci; 1968 Mar; 255():179-95. PubMed ID: 4384524
    [No Abstract]   [Full Text] [Related]  

  • 5. Rifampicin: a new rifamycin. I. Bacteriological studies.
    Arioli V; Pallanza R; Furesz S; Carniti G
    Arzneimittelforschung; 1967 May; 17(5):523-9. PubMed ID: 4385644
    [No Abstract]   [Full Text] [Related]  

  • 6. Microbiological studies on cefoperazone.
    Kayser FH
    Clin Ther; 1980; 3(Spec Issue):24-33. PubMed ID: 6446395
    [No Abstract]   [Full Text] [Related]  

  • 7. [Bacteriostatic effect of tetracyclines-macrolides associations].
    de Lajudie P
    Pathol Biol (Paris); 1971; 19(11):607-12. PubMed ID: 4397549
    [No Abstract]   [Full Text] [Related]  

  • 8. [Value of rifampicin in treatment of the patients with bronchopulmonary lesions. A clinical-bacteriological study].
    Beeuwkes H; Buytendijk HJ; Maesen FP
    Arzneimittelforschung; 1969 Aug; 19(8):1283-5. PubMed ID: 4390183
    [No Abstract]   [Full Text] [Related]  

  • 9. Antimicrobial agents--mechanisms of action and clinical usage.
    Neu HC
    Curr Probl Surg; 1973 Jun; ():1-64. PubMed ID: 4146368
    [No Abstract]   [Full Text] [Related]  

  • 10. Antimicrobial activity of MDL 19,592: an oral cephalosporin.
    Jones RN; Barry AL
    Diagn Microbiol Infect Dis; 1988 Nov; 11(3):159-62. PubMed ID: 3246143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Postantibiotic effects of ABT-773 and amoxicillin-clavulanate against Streptococcus pneumoniae and Haemophilus influenzae.
    Neuhauser MM; Prause JL; Danziger LH; Pendland SL
    Antimicrob Agents Chemother; 2001 Dec; 45(12):3613-5. PubMed ID: 11709352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Sensitivity to cefotiam of 494 hospital bacterial strains. Determination of minimal inhibitory concentration and comparison with other beta-lactams].
    Reynaud A; Desnoes M; Derriennic M; Courtieu AL
    Pathol Biol (Paris); 1985 May; 33(5):313-9. PubMed ID: 3929216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of erythromycin on adenoid bacteria.
    Palva T; Malmberg H; Lehtinen T
    Acta Otolaryngol; 1986; 101(3-4):348-52. PubMed ID: 3486544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The comparative in vitro activity of spiramycin and erythromycin against Norwegian bacterial isolates.
    Dibb WL; Ragnhildstveit E
    NIPH Ann; 1986 Dec; 9(2):61-3. PubMed ID: 3101004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emerging patterns of microbial resistance.
    Washington JA
    Orthop Clin North Am; 1984 Jul; 15(3):417-25. PubMed ID: 6433290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Is there a place for rifampicin in the treatment of bacterial bronchopulmonary infections?].
    Maesen FP; Buytendijk HJ
    Poumon Coeur; 1970; 26(2):193-7. PubMed ID: 4393036
    [No Abstract]   [Full Text] [Related]  

  • 17. Laboratory and clinical evaluation of 7-chloro-7-deoxylincomycin.
    Oppenheimer S; Turek M
    Am J Med Sci; 1968 Nov; 256(5):314-21. PubMed ID: 4386951
    [No Abstract]   [Full Text] [Related]  

  • 18. Bacteriological and pharmacological investigations with Garamycin (gentamicin).
    Nagy AE; Csatáry KN
    Acta Microbiol Acad Sci Hung; 1974; 21(3-4):289-91. PubMed ID: 4215292
    [No Abstract]   [Full Text] [Related]  

  • 19. [The extent of resistance on clinically important pathogens in the Federal Republic].
    Pulverer G
    Adv Clin Pharmacol; 1974; 8():21-32. PubMed ID: 4157112
    [No Abstract]   [Full Text] [Related]  

  • 20. [Antibiotic resistance: an always present problem].
    Debbia EA
    Recenti Prog Med; 1999 Oct; 90(10):505-9. PubMed ID: 10592734
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.